Member Info for inanaco

Crumbs you have to look at how the citrullinated peptides are presented and displayed to the immune system at no point does the cancer try to hide those peptides indeed it cannot as the cancer itself does not have its own immune system to remove "stressed cells" so in the event of Inflammation these peptides appear and what does the cancer do when under attack from Inflammation ? it defends with The PD-1 ligand to try and turn off the t cell attack ....

effectively Moditope turns on PD-1 ......... yet ignores it without the need for Keytruda

No Rats this is another new patent for the Glycan Antibody now called a "platform"

New direct killing antibody platform shortly
to be patented and available for license

that is quite an announcement .. i assume once the Patent is published RNS will follow

Anti-glycan mAbs
? Highly specific direct killing antibody
available to license
? New direct killing antibody platform shortly
to be patented and available for license

I missed that one ... who requested a 6 month extension ? and how was that presented ?

Remember Moditope is a cure for Cancer ..............

all the major cancers are in the Modi1/2/3 program....

its a big project

its a joint collaboration in how to do it .......... rather than just bolt on technology ...

Biontech can select the TCR from CD8's ... but CD4 is a different type of T cell and it can differentiate as well so the selection process is tightened up way beyond what BioNtech has done to date, hence scancell and biontech are overcoming the hurdles to this technology shift .........to CD4 being the Killing Cell ........

so don't get to hung up on dates.... June this is "New Technology"

From a Flotation ... full disclosure of a "Novel Technology" as a future direction has great benefit to the flotation value

However a full disclosure update is desirable because of the possibilities of the other "neo antigen moditopes "
being added to the program and the potential value of this given to the market by any deal signed up with if BioNtech license the first 3 epitopes VIm1/2 and Enolase

its a very exciting time ............ because 3 epitope deal could run into a lot more .... and Karolinska project is caught up in the maths to

run the SCIB2 with Nano ... test

Run SCIB1 "mark 2" with Nano if good result with SC1b2

SCIB1 mark one continue as is

just to busy to get involved at the moment ... sorry C7 (major construction project)

of the patients that are treated C7 ... 23% survive ...

so take all patients then select 25% of them ... then 23% of those will respond .....

if they changed the formula for scib1 the whole process would be reset .. and the existing data collected would be worthless

2 year shelf life ... 2019

Crumbs ... Peptides are Conservative . Strong and Stable . T May .. 2017

i think you can see what i am on about ... RNS every 2 months ordering a new batch ...

in which case its already out of date .. stale peptides

""" These are smart, financial people"""

you mean Rogue traders caught up in a web of deceit of their own making that that These smart, financial people didn't spot ... ??

You are made up of many peptides are you stable for more than a few months ... LOL

Moved the SP to Bid price .. SP is still Blue

its an injection device ... not quite the same as an electric chair

and Europe has already approved and its in use, with no related deaths

Run by Olly Robbins American Cousin ...